Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...
Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum. Supported by approximately $495 million in cash and short-term investments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results